Search research articles
Contact Us
Filters
Showing results (11-20 of 73) with videos related to
Page
of 8
Sort By:
Clinical Therapeutics
|
May 4, 2016
Corrigendum to "Descriptive Comparison of Drug Treatment-Persistent, - Nonpersistent, and Nondrug Treatment Patients With Newly Diagnosed Attention Deficit/Hyperactivity Disorder in Germany" Clin Ther 2013;35:673-685
Sebastian Braun, Leo Russo, Jan Zeidler, et al.
Clinical Therapeutics
|
April 17, 2013
Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany
Sebastian Braun, Leo Russo, Jan Zeidler, et al.
Health Economics Review
|
March 27, 2021
Note from the editor, January 2021
J-Matthias Graf von der Schulenburg, Sebastian Braun, Jan Zeidler
Health Policy (Amsterdam, Netherlands)
|
February 1, 2016
Status and perspectives of claims data analyses in Germany-A systematic review
Kristine Kreis, Sarah Neubauer, Mike Klora, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 18, 2016
Erratum to: Treatment costs of attention deficit hyperactivity disorder in Germany
Sebastian Braun, Jan Zeidler, Roland Linder, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
May 22, 2020
["But you often come unstuck on particularities" - Care consultants on legislation amendments and the challenges of their job: A qualitative investigation]
Lea de Jong, Jona Theodor Stahmeyer, Sveja Eberhard, et al.
Herz
|
January 22, 2009
[Comparative cost analysis of outpatient and inpatient rehabilitation for cardiac diseases]
Jan Zeidler, Thomas Mittendorf, Gunda Vahldiek, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 27, 2012
Treatment costs of attention deficit hyperactivity disorder in Germany
Sebastian Braun, Jan Zeidler, Roland Linder, et al.
Health Economics Review
|
July 26, 2015
Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany
Sarah Neubauer, Mary Cifaldi, Thomas Mittendorf, et al.
BMC Geriatrics
|
March 26, 2021
Willingness and preparedness to provide care: interviews with individuals of different ages and with different caregiving experiences
Lea de Jong, Jona Theodor Stahmeyer, Sveja Eberhard, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 73) with videos related to
Sort By:
Page
of 8
Clinical Therapeutics
|
May 4, 2016
Corrigendum to "Descriptive Comparison of Drug Treatment-Persistent, - Nonpersistent, and Nondrug Treatment Patients With Newly Diagnosed Attention Deficit/Hyperactivity Disorder in Germany" Clin Ther 2013;35:673-685
Sebastian Braun, Leo Russo, Jan Zeidler, et al.
Clinical Therapeutics
|
April 17, 2013
Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany
Sebastian Braun, Leo Russo, Jan Zeidler, et al.
Health Economics Review
|
March 27, 2021
Note from the editor, January 2021
J-Matthias Graf von der Schulenburg, Sebastian Braun, Jan Zeidler
Health Policy (Amsterdam, Netherlands)
|
February 1, 2016
Status and perspectives of claims data analyses in Germany-A systematic review
Kristine Kreis, Sarah Neubauer, Mike Klora, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 18, 2016
Erratum to: Treatment costs of attention deficit hyperactivity disorder in Germany
Sebastian Braun, Jan Zeidler, Roland Linder, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
May 22, 2020
["But you often come unstuck on particularities" - Care consultants on legislation amendments and the challenges of their job: A qualitative investigation]
Lea de Jong, Jona Theodor Stahmeyer, Sveja Eberhard, et al.
Herz
|
January 22, 2009
[Comparative cost analysis of outpatient and inpatient rehabilitation for cardiac diseases]
Jan Zeidler, Thomas Mittendorf, Gunda Vahldiek, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 27, 2012
Treatment costs of attention deficit hyperactivity disorder in Germany
Sebastian Braun, Jan Zeidler, Roland Linder, et al.
Health Economics Review
|
July 26, 2015
Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany
Sarah Neubauer, Mary Cifaldi, Thomas Mittendorf, et al.
BMC Geriatrics
|
March 26, 2021
Willingness and preparedness to provide care: interviews with individuals of different ages and with different caregiving experiences
Lea de Jong, Jona Theodor Stahmeyer, Sveja Eberhard, et al.
Page
of 8